Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

Systematic Review, Meta-Analysis, and Quality Appraisal of Advanced Machine Learning Risk Models for Cancer-Associated Thrombosis: The Emergence of Artificial Intelligence in Thrombosis Research

Nicole M. Kuderer, Gary H. Lyman

Blood (2024) 144 (Supplement 1): 4025.

https://doi.org/10.1182/blood-2024-211153

Published: 2024

Journal Articles

High Prevalence of Subjective Minimizing Language in Clinical Trials of Hematologic Malignancies: Natural Language Processing (NLP) Validation Study and Systematic Review of Randomized Controlled Trials Presented at ASH 2009-2021

Benjamin Chin-Yee, Tiancheng Hu, Clarissa Skorupski, Sarah Ghnaim, Bishal Gyawali, Turab Mohammed, James Yu, Gary H. Lyman, Michelle Sholzberg, Lisa Hicks, Nicole M. Kuderer

Blood (2023) 142 (Supplement 1): 3709.

https://doi.org/10.1182/blood-2023-180132

Published: 2023

Journal Articles

Toxicity Reporting Is Inconsistent and Incomplete, and Subjective Minimizing Language Is Common in Acute Leukemia Clinical Trials: A Systematic Review of Randomized Controlled Trials Presented at ASH between 2017-2021

Benjamin Chin-Yee, Turab Mohammed, Clarissa Skorupski, Bishal Gyawali, Gary H. Lyman, Lisa K. Hicks, Dr. Nicole M.M. Kuderer

Blood (2022) 140 (Supplement 1): 317–318.

https://doi.org/10.1182/blood-2022-157860

Published: 2022

Journal Articles

Inconsistent Adverse Event Reporting: A Systematic Review of Phase 3 Lymphoma or Myeloma Trials Presented at ASH Annual Meetings between 2017-2021

Clarissa Skorupski, Turab Mohammed, Benjamin Chin-Yee, Bishal Gyawali, Gary H. Lyman, Nicole M. Kuderer, Lisa K. Hicks

Blood (2022) 140 (Supplement 1): 5060–5061.

https://doi.org/10.1182/blood-2022-162981

Published: 2022

Journal Articles

Identification of Risk Factors for and Development of a Predictive Model for Immunotherapy-Associated Venous Thromboembolism (VTE) in Patients with Non-Small Cell Lung Cancer

Kristen M. Sanfilippo, Suhong Luo, Gary H. Lyman, David C. Calverley, Dr. Nicole M.M. Kuderer

Blood (2022) 140 (Supplement 1): 2803–2804.

https://doi.org/10.1182/blood-2022-165748

Published: 2022

Journal Articles

Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry

Blood (2020) 136 (Supplement 1): 56–58.

https://doi.org/10.1182/blood-2020-138834

Published: 2020

Journal Articles

Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis

Samuel Rubinstein, MD, Ryan C. Lynch, MD, Aakash Desai, MD, Catherine Stratton, MPH, Alokkumar Jha, PhD, Ziad Bakouny, MD MSc, Andrew Schmidt, MD, R. Alejandro Sica, MD, Divaya Bhutani, MD, Dimpy P. Shah, MD PhD, Sarah A Wall, MD, Gary H. Lyman, MD, Nicole M. Kuderer, MD MSc, Matthias Weiss, MD PhD, Jeremy L. Warner, MD MS, Keith E. Stockerl-Goldstein, MD, Ruben Mesa, MD, Michael A. Thompson, MD PhD

Blood (2020) 136 (Supplement 1): 28–30.

https://doi.org/10.1182/blood-2020-141937

Published: 2020

Journal Articles

Predictors of Febrile Neutropenia Among Cancer Patients Receiving Myelosuppressive Chemotherapy in US Clinical Practice

Gary H. Lyman, MD MPH, Kathryn Richert-Boe, MD MPH, Lois Lamerato, PhD, Manpreet Kaur, MPH, MBA, Neel Shah, BPharm, PhD, Tatiana Lawrence, MD, Devi Sundaresan, MS, Amanda Silvia, BS, Ahuva Hanau, BS, Derek Weycker, PhD

Blood (2019) 134 (Supplement_1): 5854.

https://doi.org/10.1182/blood-2019-123524

Published: 2019

Journal Articles

Cancer Associated Thrombosis Is Associated with Higher Mortality across All Khorana Score Risk Levels

Alok A Khorana, MD, Keith R McCrae, MD, Nicole M. Kuderer, Dejan Milentijevic, François Laliberté, Guillaume Germain, MSc, Sean D. MacKnight, Patrick Lefebvre, Gary H. Lyman, MD MPH, Michael B. Streiff, MD

Blood (2019) 134 (Supplement_1): 1143.

https://doi.org/10.1182/blood-2019-129090

Published: 2019

Journal Articles

Effectiveness of Prophylaxis with Granulocyte Colony-Stimulating Factor Among Cancer Patients Receiving Myelosuppressive Chemotherapy in US Clinical Practice

Kathryn Richert-Boe, MD MPH, Lois Lamerato, PhD, Gary H. Lyman, MD MPH, Manpreet Kaur, MPH, MBA, Neel Shah, BPharm, PhD, Tatiana Lawrence, MD, Devi Sundaresan, MS, Amanda Silvia, BS, Ahuva Hanau, BS, Derek Weycker, PhD

Blood (2019) 134 (Supplement_1): 4688.

https://doi.org/10.1182/blood-2019-123559

Published: 2019

Journal Articles

Safety and Effectiveness of Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Venous Thrombosis: A SEER-Medicare-Linked Data Analysis

Christine G. Kohn, PharmD, Gary H. Lyman, MD MPH, Nicole M. Kuderer, Thomas J. Bunz, PharmD, PhD, Craig I. Coleman, PharmD

Blood (2019) 134 (Supplement_1): 3673.

https://doi.org/10.1182/blood-2019-128581

Published: 2019

Journal Articles

Health Care Costs Associated with Contemporary Chronic Myelogenous Leukemia (CML) Therapy Compared to Other Hematologic Malignancies (HEM)

Jennifer J. Wilkes, MDMSCE, Gary H. Lyman, MD MPH, David R Doody, MS, Shasank R Chennupati, PharmD, MPH, Laura Becker, MS, Pamela E Morin, Lena E. Winestone, MD MSHP, Henry (Joe) Henk, PhD, Eric J Chow, MD MPH

Blood (2019) 134 (Supplement_1): 4753.

https://doi.org/10.1182/blood-2019-124106

Published: 2019

Journal Articles

Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis

Ang Li, MD, Josh J Carlson, PhD, Nicole M. Kuderer, Jordan K Schaefer, MD, Shan Li, PharmD, David A. Garcia, MD, Alok A Khorana, MD, Marc Carrier, MD, Gary H. Lyman, MD MPH

Blood (2019) 134 (Supplement_1): 4669.

https://doi.org/10.1182/blood-2019-127917

Published: 2019

Journal Articles

Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)

Blood (2018) 132 (Supplement 1): LBA-1.

https://doi.org/10.1182/blood-2018-120738

Published: 2018

Journal Articles

The Rate of Venous Thromboembolism in Cancer Patients Varies By Khorana Risk Category

Alok A. Khorana, MD, Nicole M. Kuderer, MD, Keith R. McCrae, MD, Dejan Milentijevic, PhD, Guillaume Germain, MA, François Laliberté, MA, Nguyen Le, BSc, Patrick Lefebvre, MA, Gary H. Lyman, MD MPH, FRCP, Michael B. Streiff, MD

Blood (2018) 132 (Supplement 1): 3798.

https://doi.org/10.1182/blood-2018-99-116224

Published: 2018

Journal Articles

Healthcare Costs in Patients with Cancer Increase with Increasing Risk of Venous Thromboembolism

Michael B. Streiff, MD, Keith R. McCrae, MD, Nicole M. Kuderer, MD, Dejan Milentijevic, PhD, Guillaume Germain, MA, François Laliberté, MA, Nguyen Le, BSc, Patrick Lefebvre, MA, Gary H. Lyman, MD MPH, FRCP, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 3799.

https://doi.org/10.1182/blood-2018-99-117121

Published: 2018

Journal Articles

The Incidence of Thromboembolism for Lenalidomide Versus Thalidomide in Older Patients with Newly Diagnosed Multiple Myeloma

Ang Li, MD, Qian V. Wu, PhD, Greg Warnick, Edward N. Libby, III, MD, David A. Garcia, MD, Gary H. Lyman, MD MPH, FRCP

Blood (2018) 132 (Supplement 1): 361.

https://doi.org/10.1182/blood-2018-99-110500

Published: 2018

Journal Articles

Cost of Care at NCI-Designated Comprehensive Cancer Centers Vs. Other Treatment Sites for Young Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia (ALL)

Julie A. Wolfson, MD MS, Smita Bhatia, MD MPH, Jill Ginsberg, MD, Laura Becker, MS, David Bernstein, Henry (Joe) Henk, PhD, Gary H. Lyman, MD MPH, FRCP, Paul Nathan, MD, Diane Puccetti, MD, Jennifer J. Wilkes, MD, Lena E. Winestone, MD, Kelly Kenzik, PhD

Blood (2018) 132 (Supplement 1): 3531.

https://doi.org/10.1182/blood-2018-99-110649

Published: 2018

Journal Articles

The HAS-RISC Score for Venous Thromboembolism (VTE) Risk Stratification in Newly Diagnosed Multiple Myeloma Patients Starting Immunomodulatory Drugs (IMID)

Ang Li, MD, Qian V. Wu, PhD, Greg Warnick, Neil A Zakai, MD MSc, Edward N. Libby, III, MD, David A. Garcia, MD, Gary H. Lyman, MD MPH, FRCP

Blood (2018) 132 (Supplement 1): 144.

https://doi.org/10.1182/blood-2018-99-110567

Published: 2018

Journal Articles

A Systematic Literature Review of Overall Survival and Delivered Dose Intensity in Cancer Patients Receiving Chemotherapy and G-CSF in Randomized Control Trials

Gary H. Lyman, MD MPH, FRCP, Lillian Yau, Roumen Nakov, Andriy Krendyukov

Blood (2017) 130 (Supplement 1): 3424.

https://doi.org/10.1182/blood.V130.Suppl_1.3424.3424

Published: 2017

NARROW

Systematic Review, Meta-Analysis, and Quality Appraisal of Advanced Machine Learning Risk Models for Cancer-Associated Thrombosis: The Emergence of Artificial Intelligence in Thrombosis Research

High Prevalence of Subjective Minimizing Language in Clinical Trials of Hematologic Malignancies: Natural Language Processing (NLP) Validation Study and Systematic Review of Randomized Controlled Trials Presented at ASH 2009-2021

Toxicity Reporting Is Inconsistent and Incomplete, and Subjective Minimizing Language Is Common in Acute Leukemia Clinical Trials: A Systematic Review of Randomized Controlled Trials Presented at ASH between 2017-2021

Inconsistent Adverse Event Reporting: A Systematic Review of Phase 3 Lymphoma or Myeloma Trials Presented at ASH Annual Meetings between 2017-2021

Identification of Risk Factors for and Development of a Predictive Model for Immunotherapy-Associated Venous Thromboembolism (VTE) in Patients with Non-Small Cell Lung Cancer

Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry

Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis

Predictors of Febrile Neutropenia Among Cancer Patients Receiving Myelosuppressive Chemotherapy in US Clinical Practice

Cancer Associated Thrombosis Is Associated with Higher Mortality across All Khorana Score Risk Levels

Effectiveness of Prophylaxis with Granulocyte Colony-Stimulating Factor Among Cancer Patients Receiving Myelosuppressive Chemotherapy in US Clinical Practice

Safety and Effectiveness of Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Venous Thrombosis: A SEER-Medicare-Linked Data Analysis

Health Care Costs Associated with Contemporary Chronic Myelogenous Leukemia (CML) Therapy Compared to Other Hematologic Malignancies (HEM)

Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis

Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)

The Rate of Venous Thromboembolism in Cancer Patients Varies By Khorana Risk Category

Healthcare Costs in Patients with Cancer Increase with Increasing Risk of Venous Thromboembolism

The Incidence of Thromboembolism for Lenalidomide Versus Thalidomide in Older Patients with Newly Diagnosed Multiple Myeloma

Cost of Care at NCI-Designated Comprehensive Cancer Centers Vs. Other Treatment Sites for Young Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia (ALL)

The HAS-RISC Score for Venous Thromboembolism (VTE) Risk Stratification in Newly Diagnosed Multiple Myeloma Patients Starting Immunomodulatory Drugs (IMID)

A Systematic Literature Review of Overall Survival and Delivered Dose Intensity in Cancer Patients Receiving Chemotherapy and G-CSF in Randomized Control Trials

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only